论文部分内容阅读
耐甲氧西林金黄色葡萄球菌(MRSA)是常见的多重耐药菌之一,除了万古霉素和利奈唑胺等少数抗菌药外,它几乎对现有所有抗菌药物耐药,是导致严重医院和社区感染的重要病原菌。MRSA感染患者的死亡率较高,并且近年来MRSA的发生率逐年增长,是世界公共卫生面临的巨大挑战。因此,临床迫切需要新的抗菌药物,以克服越来越严
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the common multi-drug resistant bacteria. Apart from a few antibacterials, such as vancomycin and linezolid, it is resistant to almost all existing antibacterial drugs and causes severe hospital And the community is infected with important pathogens. MRSA infection in patients with higher mortality, and the incidence of MRSA in recent years, increasing year by year, is the world public health challenges. Therefore, the urgent need for clinical new antibacterial drugs to overcome more and more strict